KemPharma Revenue, Profits - KMPH Annual Income Statement

Add to My Stocks
$4.68 $0.27 (5.45%) KMPH stock closing price Sep 20, 2018 (Closing)

KMPH stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the KemPharma stock price. An income statement is one of the three key financial statements furnished by a company, the other two being the balance sheet and the cashflow statement. When compared with the corresponding income statement from the past, the latest income statement shows how revenue has decreased from - to - and how operating and non operating activities have impacted the KMPH stock. The KemPharma profit and loss statement for 2017 shows a net profit of $-43.38M. Profits for last year was $-16.51M. Apart from this an investor should also check KemPharma assets and KemPharma free cash flow.

View revenue and profit details for latest and last 10 financial years.
show more
Fiscal year is Jan - Dec20172016201520142013
KemPharma Revenues or Net Sales
-----
Cost Of Goods Sold (COGS)-----
KemPharma Gross Profit
-----
Research & Development Expense20.59M20.47M13.93M11.91M3.36M
Selling General & Admin Expense12.77M17.01M8.88M4.52M1.35M
Income Before Depreciation Depletion Amortization-33.36M-37.48M-22.81M-16.44M-4.71M
Depreciation Depletion Amortization-----
Non Operating Income-2.72M28.07M-29.15M-5.31M1.18M
Interest Expense7.33M7.12M2.67M2.71M1.71M
KemPharma Pretax Income
-43.42M-16.53M-54.63M-24.47M-5.24M
Provision for Income Taxes-0.04M-0.01M--0.02M-0.01M
MinorityInterest-----
Investment Gains Losses-----
Other Income-----
Income Before Extraordinaries & Disc Operations-43.38M-16.51M-54.66M-24.45M-5.22M
Extraordinary Items & Discontinued Operations-----
KemPharma Profit/ Loss (Net Income)
-43.38M-16.51M-54.66M-24.45M-5.22M
Average Shares used to compute Diluted EPS14.65M14.6M7.37M2.38M-
Average Shares used to compute Basic EPS14.65M14.6M7.37M2.38M-
Income Before Nonrecurring Items-43.39M-16.52M-40.96M-24.56M-
Income from Nonrecurring Items---13.71M--
KemPharma Earnings Per Share Basic Net
-2.96-1.13-7.42-10.27-
KemPharma Earnings Per Share Diluted Net
-2.96-1.13-7.42-10.27-
EPS Diluted Before Nonrecurring Items-2.96-1.13-5.56-10.27-
Preferred Dividends Acc Pd-----
Dividends Common-----
Dividend Per Share Common0.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.

Before investing one should read a report on KemPharma stock analysis. It helps to look at the following income statement items:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that KMPH stock has a topline or revenue of $- for 2017 as per this KemPharma revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The bottomline or the net income figure is arrived at by deducting all expenses from the topline which in this case is $-43.38M for KMPH stock. An improving bottomline implies that the company is growing its profits.

The income statement is also called statement of revenue and expense. The KMPH financials along with KemPharma historical stock prices provide a lot of details about the firm.

KemPharma Income Statement - Key Financial Ratios